CQRLF yields 5571.03% · JNJ yields 2.13%● Live data
📍 CQRLF pulled ahead of the other in Year 1
Combined, CQRLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CQRLF + JNJ for your $10,000?
Conquest Resources Limited, together with its subsidiaries, engages in the exploration, evaluation, and development of mineral properties in northern Ontario. It explores for gold, copper, and other base metal properties. The company holds a 100% interest in the Belfast- TeckMag property that consists of 4 mining leases and 773 mining claim cells located at Emerald Lake; the Alexander property that consists of 27 patented claims covering 448 hectares situated in the Red Lake mining district; the Smith Lake property, which consists of 6 patented mining leases and 181 mining claims covering approximately 2,915 hectares located in the Missinabie-Goudreau greenstone belt, Ontario; and the King Bay property, which include mining lease and patented mining claims situated in Sturgeon Lake, Ontario. It also entered into an agreement to acquire 100% interest in the Lake Nipigon Basin uranium property located in the south of Black Sturgeon Lake in Nipigon, Ontario. The company was incorporated in 1945 and is headquartered in Toronto, Canada.
Full CQRLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.